This is the wall of fire. I don't blame you for feeling this way. Fear in these moments is real, and sometimes well-warranted. We'll find out once a few announcements roll out post-ASX delisting. If psiGAD phase two results are positive, and/or IHL-42x first interim results are positive, and the NASDAQ doesn't respond favorably, that's when we'll know more definitively what our mid-term outlook is. But even then, the trial by fire may not be over. Sometimes share prices stay in the dog house until the verge of commercialisation, or first profits.
I maintain that the current situation is largely explained by factors beyond the BOD's control: I'm counting on them to successfully launch Clarion clinics, and conduct their trials in the optimal manner so that we can find out the viability of the drug candidates. On those fronts, so far so good. But your fear is understandable.
IHL Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
